Stock 27F0 KALA BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News KALA BIO, Inc. Deutsche Boerse AG

Equities

27F0

US4831192020

Real-time Estimate Tradegate
Other stock markets
 14:56:52 2024-07-05 EDT 		5-day change 1st Jan Change
6.448 EUR +4.08% Intraday chart for KALA BIO, Inc. -0.16% -6.43%
06-28 KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP CI
06-27 Top Midday Gainers MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP
CI
Top Midday Gainers
MT
Sector Update: Health Care Stocks Mixed Premarket Thursday
MT
Kala Bio to Raise $12.5 Million in Private Placement; Shares Jump
MT
KALA BIO Announces $12,500,000 Private Placement
AQ
KALA BIO, Inc. announced that it expects to receive $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP
CI
KALA BIO : Corporate Overview - June 2024
PU
KALA BIO to Present at Jefferies Global Healthcare Conference
AQ
HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating
MT
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
AQ
HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating
MT
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
AQ
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
AQ
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP
CI
North American Morning Briefing : Stocks Struggle After New Records
DJ
North American Morning Briefing : Inflation -2-
DJ
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KALA Stock
  4. 27F0 Stock
  5. News KALA BIO, Inc.